PTBP1 and adenoma: We found that PTBP1 displayed the more frequent strong immunoreactivity both in colorectal cancer samples (56.3%, 89/158) and adenomas (77.2%, 34/44) which comparing with normal colon epithelium (10%, 11/106) (P<0.001, respectively).